Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials

Cites (221)

Items 201–221 of 221

1. Considerations in the Development of Drugs to Treat Sarcopenia
   Eric P. Brass, Kathy E. Sietsema · 2011 · Journal of the American Geriatrics Society
2. Muscle Blood Flow and Mitochondrial Function: Influence of Aging
   Ronald L. Terjung, Ryszard Zarzeczny, Han Yang · 2002 · International Journal of Sport Nutrition and Exercise Metabolism
3. Hydrogen Peroxide‐Dependent Arteriolar Dilation in Contracting Muscle of Rats Fed Normal and High Salt Diets
   Paul J. Marvar, Leah W. Hammer, Matthew A. Boegehold · 2007 · Microcirculation
4. The Ligand Binding Battle at Cytochrome c Oxidase
   Mark T. Gladwin, Sruti Shiva · 2009 · Circulation Research
5. Estradiol exerts antiapoptotic effects in skeletal myoblasts via mitochondrial PTP and MnSOD
   Anabela Belén la Colla, Andrea Vasconsuelo, Ricardo Boland · 2012 · Journal of Endocrinology
6. Comparative morphological study of age related mitochondrial changes of the lymphocytes and skeletal muscle cells.
   Edit Beregi, O Regius · 1987 · PubMed
7. Mitophagy: A process that adapts to the cell physiology
   Ingrid Bhatia‐Kiššová, Nadine M. Camougrand · 2012 · The International Journal of Biochemistry & Cell Biology
8. MAGING, FUNCTIONAL AND BIOLOGICAL MARKERS FOR SARCOPENIA: THE PURSUIT OF THE GOLDEN RATIO
   Emanuele Marzetti · 2012 · The Journal of Frailty & Aging
9. Target population for clinical trials
   Stephanie A. Studenski · 2009 · The journal of nutrition health & aging
10. Subcellular effects of myocyte-specific androgen receptor overexpression in mice
    Mutaz Musa, Shannon M. Fernando, Diptendu Chatterjee, D. Ashley Monks · 2011 · Journal of Endocrinology
11. From isolated to networked: a paradigmatic shift in mitochondrial physiology
    Miguel Antonio Aon · 2010 · Frontiers in Physiology
12. Differential effects of aging and exercise on intra-abdominal adipose arteriolar function and blood flow regulation
    Robert T. Davis, John N. Stabley, James M. Dominguez, Michael W. Ramsey, Danielle J. McCullough, Lisa A. Lesniewski, Michael D. Delp, Bradley Jon Behnke · 2013 · Journal of Applied Physiology
13. Designing phase II B trials in sarcopenia: The best target population
    Marco Pahor, Matteo Cesari · 2011 · The journal of nutrition health & aging
14. Myonuclear domain in skeletal muscle fibers. A critical review
    Carlos Eduardo Teixeira, José Alberto Duarte · 2011 · Archives of Exercise in Health and Disease
15. Sarcopenia: Current Clinical and Research Issues
    Matteo Cesari, Alessandro Ferrini, Valentina Zamboni, Marco Pahor · 2008 · The Open Geriatric Medicine Journal
16. Myonuclear domain in skeletal muscle fibers. A crit ical review.
    Carlos Eduardo Garcez Teixeira, José Alberto Duarte · 2011 · Archives of Exercise in Health and Disease
17. BIOMARKERS OF SARCOPENIA IN CLINICAL TRIALS RECOMMENDATIONS FROM THE INTERNATIONAL WORKING GROUP ON SARCOPENIA
    Matteo Cesari, Roger A. Fielding, Marco Pahor, Bret H. Goodpaster, M K Hellerstein, Gabor Abellán van Kan, Stefan D. Anker, Seward B. Rutkove, Jan Willem Vrijbloed, Maria Isaac et al. · 2012 · The Journal of Frailty & Aging
18. Mitofusin function is dependent on the distinct tissue and organ specific roles of mitochondria
    Michael N. Sack · 2011 · Journal of Molecular and Cellular Cardiology
19. Commentaries on Viewpoint: Muscle atrophy is not always sarcopenia
    Dominique P. Dardevet, Isabelle Savary‐Auzeloux, Didier Rémond, Laurent Mosoni, Emanuele Marzetti, Thomas W Buford, Roberto Bernabei, Isabelle J. Dionne, Thomas W Buford, Emanuele Marzetti et al. · 2012 · Journal of Applied Physiology
20. Untitled work
    1999 · 10.1002/(sici)1097-4598(199910)22:10
21. Untitled work
    1997 · 10.1002/(sici)1097-0185(199707)248:3